Fig. 6: Prominent NE defect occurs under conditions of synthetic lethality.
From: Mitotic DNA repair by TMEJ suppresses replication stress-induced nuclear envelope reassembly defect

a Representative images of GFP-BAF with the indicated treatments for 48âh. b Quantification of cells with BAF foci for (a). Data are presented as meanâÂħâSD, nâ=â3 independent experiments, Nâ>â200 for each experiment. Statistical analysis is performed by two-tailed unpaired Studentâs t-test. c Viability assay of RPE-1 cells with the indicated concentrations of ATR-i (VE-821)âÂħâAPH treatment for 48âh. Values under different conditions are normalized to the value in DMSO treatment without ATR-i. Data are presented as meanâÂħâSD, nâ=â9 independent experiments. Statistical analysis is performed by two-way ANOVA. d Representative images of GFP-BAF in WT or BRCA2â/â cells after treatment with DMSO or 5âÎĵM PARP-i (Olaparib) for 48âh. Two BRCA2â/â clones with different genotypes are included. e Quantification of WT or BRCA2â/â cells with BAF foci with indicated treatments. Data are presented as meanâÂħâSD, nâ=â3 independent experiments, Nâ>â250 for each experiment. Two-way ANOVA is performed for different groups. Two-tailed unpaired Studentâs t-test is performed for interested pairs (ns pâ>â0.05, *pâ<â0.05, **pâ<â0.01, ***pâ<â0.001). f Viability assay for WT or BRCA2â/â cells with treatment of the indicated concentrations of PARP-i. Data are presented as meanâÂħâSD, nâ=â3 independent experiments. Statistical analysis is performed by two-way ANOVA. g Representative images of GFP-BAF in WT or BRCA2â/â cells after treatment of DMSO or 5âÎĵM Polθ-i (ART558) for 48âh. h Quantification of WT or BRCA2â/â cells with BAF foci after treatment with the indicated concentrations of Polθ-i for 48âh. Data are presented as meanâÂħâSD, nâ=â3 independent experiments, Nâ>â250 for each experiment. Two-way ANOVA is performed for different groups. Two-tailed unpaired Studentâs t-test is performed for interested pairs (ns pâ>â0.05, *pâ<â0.05, **pâ<â0.01, ***pâ<â0.001). i Viability assay for WT or BRCA2â/â cells with treatment of the indicated concentrations of Polθ-i. Data are presented as meanâÂħâSD, nâ=â3 independent experiments. Statistical analysis is performed by two-way ANOVA. For (a, d, g), scale barâ=â10âÎĵm. Source data are provided as a Source Data file.